Evaluation of Immunogenicity and Safety of the New Tetanus-Reduced Diphtheria Vaccines (GC 1107) in Healthy Korean Adolescents: A Phase II, Double-Blind, Randomised, Multicentre Clinical Trial

Trial Profile

Evaluation of Immunogenicity and Safety of the New Tetanus-Reduced Diphtheria Vaccines (GC 1107) in Healthy Korean Adolescents: A Phase II, Double-Blind, Randomised, Multicentre Clinical Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2013

At a glance

  • Drugs GC 1107 (Primary) ; Diphtheria-tetanus vaccine
  • Indications Diphtheria; Tetanus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top